Immortal Dragons is a Singapore-based investment fund focused on longevity and extending healthy human life. With $40 million in assets, it supports over 15 companies working on gene therapies, cryopreservation, 3D bioprinting, and regenerative medicine. Founded by Boyang Wang, the fund uses its own capital to invest quickly in high-risk, high-impact scientific projects that traditional investors often ignore. Beyond investing, it promotes global awareness by translating longevity books, sponsoring conferences, and supporting Chinese-language platforms. Immortal Dragons aims to unite science, funding, and public engagement to treat aging as a solvable problem and make life-extension technologies more accessible.